A detailed history of Lpl Financial LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Lpl Financial LLC holds 183,088 shares of TAK stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183,088
Previous 171,550 6.73%
Holding current value
$2.45 Million
Previous $2.22 Million 17.21%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$13.0 - $15.08 $149,994 - $173,993
11,538 Added 6.73%
183,088 $2.6 Million
Q2 2024

Aug 07, 2024

SELL
$12.6 - $13.67 $1,398 - $1,517
-111 Reduced 0.06%
171,550 $2.22 Million
Q1 2024

May 10, 2024

BUY
$13.89 - $15.04 $708,792 - $767,476
51,029 Added 42.3%
171,661 $2.38 Million
Q4 2023

Feb 14, 2024

BUY
$13.36 - $15.43 $178,302 - $205,928
13,346 Added 12.44%
120,632 $1.72 Million
Q3 2023

Nov 13, 2023

SELL
$15.03 - $16.32 $13,076 - $14,198
-870 Reduced 0.8%
107,286 $1.66 Million
Q2 2023

Jul 31, 2023

BUY
$15.57 - $17.11 $49,092 - $53,947
3,153 Added 3.0%
108,156 $1.7 Million
Q1 2023

May 10, 2023

BUY
$15.28 - $16.48 $563,068 - $607,288
36,850 Added 54.07%
105,003 $1.73 Million
Q4 2022

Feb 07, 2023

BUY
$12.42 - $15.62 $675,449 - $849,478
54,384 Added 394.97%
68,153 $1.06 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $6,924 - $15,499
541 Added 4.09%
13,769 $179,000
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $6,966 - $7,980
-531 Reduced 3.86%
13,228 $186,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $112,598 - $127,650
-8,316 Reduced 37.67%
13,759 $197,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $192,097 - $239,210
-14,586 Reduced 39.79%
22,075 $301,000
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $21,027 - $22,265
1,290 Added 3.65%
36,661 $601,000
Q2 2021

Aug 13, 2021

BUY
$16.55 - $18.64 $54,631 - $61,530
3,301 Added 10.29%
35,371 $595,000
Q1 2021

May 14, 2021

BUY
$16.71 - $19.9 $65,603 - $78,127
3,926 Added 13.95%
32,070 $586,000
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $30,318 - $37,370
-1,970 Reduced 6.54%
28,144 $512,000
Q3 2020

Nov 09, 2020

SELL
$17.1 - $19.19 $59,200 - $66,435
-3,462 Reduced 10.31%
30,114 $537,000
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $7,820 - $10,452
-536 Reduced 1.57%
33,576 $602,000
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $235,518 - $367,387
18,089 Added 112.89%
34,112 $518,000
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $76,702 - $94,651
4,544 Added 39.59%
16,023 $316,000
Q3 2019

Nov 13, 2019

BUY
$16.15 - $17.99 $21,705 - $24,178
1,344 Added 13.26%
11,479 $197,000
Q2 2019

Aug 09, 2019

SELL
$16.58 - $20.49 $375,769 - $464,385
-22,664 Reduced 69.1%
10,135 $179,000
Q1 2019

May 08, 2019

BUY
$16.7 - $21.52 $547,743 - $705,834
32,799 New
32,799 $668,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.6B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.